The Annals Summaries of the Latest Medical Research!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 34, No. 5, pp. 600-605. DOI 10.1345/aph.19086
© 2000 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiGiacinto, J.
Right arrow Articles by Hoie, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiGiacinto, J.
Right arrow Articles by Hoie, E.


Research Articles

Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes

JL DiGiacinto, KM Olsen, KL Bergman, and EB Hoie

OBJECTIVE: To determine the stability of lansoprazole and omeprazole suspensions at ambient and refrigerated temperatures using HPLC. DESIGN: The contents of lansoprazole and omeprazole capsules were suspended in separate flasks containing sodium bicarbonate 8.4% to concentrations of 3 and 2 mg/mL, respectively. The contents of each flask were drawn into six amber-colored oral syringes, with one-half of the syringes stored at 22 degrees C (ambient) and the other half at 4 degrees C. Lansoprazole and omeprazole concentrations were determined by a stability-indicating HPLC assay at baseline and at 4, 8, 12, and 24 hours, and on days 4, 7, 14, 21, 30, 45, and 60 after mixing. Both omeprazole and lansoprazole were considered stable if they retained > or =90% of the baseline drug concentration. RESULTS: Omeprazole was stable for up to 14 days at 22 degrees C and 45 days at 4 degrees C. Lansoprazole was stable for eight hours at 22 degrees C and for 14 days at 4 degrees C. CONCLUSIONS: When compared with ambient or refrigerated storage conditions, omeprazole was stable for a longer duration than lansoprazole. Pharmacists may use these results to guide compounding and storage of proton-pump inhibitor suspensions.


This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
J. E. Burnett and E. R. Balkin
Stability and viscosity of a flavored omeprazole oral suspension for pediatric use
Am. J. Health Syst. Pharm., November 15, 2006; 63(22): 2240 - 2247.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
B. L. Magnuson, T. M. Clifford, L. A. Hoskins, and A. C. Bernard
Enteral Nutrition and Drug Administration, Interactions, and Complications
Nutr Clin Pract, December 1, 2005; 20(6): 618 - 624.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
J. W Devlin, L. S Welage, and K. M Olsen
Proton Pump Inhibitor Formulary Considerations in the Acutely Ill Part 1: Pharmacology, Pharmacodynamics, and Available Formulations
Ann. Pharmacother., October 1, 2005; 39(10): 1667 - 1677.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
L. S. Welage
Overview of pharmacologic agents for acid suppression in critically ill patients
Am. J. Health Syst. Pharm., May 15, 2005; 62(10_Supplement_2): S4 - S10.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2000 by Harvey Whitney Books Company.